We are very excited to announce that our another pharmaceutical excipient Synthetic Beeswax has been activated, and the CDE registration status has changed from “I” to “A”, which means that it is approved by NMPA to be used in marketed preparations. More detailed information can be found in National Medical Products Administration Drug Evaluation Center.
Synthetic Beeswax is a mixture of beeswax with other ingredients, it mimics the ph犀利士ysical and chemical properties of pure beeswax, and can be a cost-effective substitute of pure beeswax. It is usually used as matrix in ointment, which can improve consistency, stability and adhesion of the ointment.
As a mixed excipient with high stability, the activation of the registration status of synthetic beeswax not only lays a good foundation for Fumei’s development of new excipients, but also provides new excipients for pharmaceutical enterprises, which promotes enterprises to further improve their products, processes and quality, and helps them to realize the development and production of more original and innovative drugs.
